KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Equity (2016 - 2025)

Neogenomics (NEO) has disclosed Return on Equity for 15 consecutive years, with 0.13% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 4.0% year-over-year to 0.13%, compared with a TTM value of 0.13% through Dec 2025, down 4.0%, and an annual FY2025 reading of 0.12%, down 4.0% over the prior year.
  • Return on Equity was 0.13% for Q4 2025 at Neogenomics, up from 0.13% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.07% in Q2 2021 and bottomed at 0.16% in Q3 2022.
  • Average Return on Equity over 5 years is 0.08%, with a median of 0.09% recorded in 2023.
  • The sharpest move saw Return on Equity rose 8bps in 2021, then dropped -21bps in 2022.
  • Year by year, Return on Equity stood at 0.01% in 2021, then plummeted by -1830bps to 0.14% in 2022, then surged by 35bps to 0.09% in 2023, then rose by 7bps to 0.09% in 2024, then plummeted by -48bps to 0.13% in 2025.
  • Business Quant data shows Return on Equity for NEO at 0.13% in Q4 2025, 0.13% in Q3 2025, and 0.12% in Q2 2025.